HawaiiSB 4802025–2026 Regular Session (Year 2)Senate

RELATING TO HEALTH.

Sponsored By: Joy A. San Buenaventura (Democratic)

In Committee

Summary

Prohibits drug manufacturers and wholesale distributors from restricting or denying access for pharmacies contracted with 340B covered entities to purchase 340B drugs at a discounted price under the federal 340B Drug Pricing Program. Imposes civil penalties for engaging in unfair or deceptive acts or practices in the conduct of any trade or commerce.

Department of HealthAffordable Health CarePrescription Drugs340B Drug Pricing ProgramPharmaciesCovered EntitiesDiscriminatory PracticesHHS, CPN/JDC

Your PRIA Score

Score Hidden

Personalized for You

How does this bill affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & Cosponsors

Sponsor

  • Joy A. San Buenaventura

    Democratic • Senate

Cosponsors

  • Carol Fukunaga

    Democratic • Senate

Roll Call Votes

No roll call votes available for this bill.

Actions Timeline

  1. Carried over to 2026 Regular Session.

    12/8/2025
  2. The committee on HHS deferred the measure.

    2/10/2025Senate
  3. The committee(s) on HHS has scheduled a public hearing on 02-10-25 1:20PM; Conference Room 225 & Videoconference.

    2/4/2025Senate
  4. Referred to HHS, CPN/JDC.

    1/21/2025Senate
  5. Introduced.

    1/17/2025Senate
  6. Passed First Reading.

    1/17/2025Senate

Bill Text

Related Bills

Back to State Legislation